A practical comparison of group-sequential and adaptive designs - PubMed (original) (raw)
Comparative Study
A practical comparison of group-sequential and adaptive designs
Patrick J Kelly et al. J Biopharm Stat. 2005.
Abstract
Sequential methods provide a formal framework by which clinical trial data can be monitored as they accumulate. The results from interim analyses can be used either to modify the design of the remainder of the trial or to stop the trial as soon as sufficient evidence of either the presence or absence of a treatment effect is available. The circumstances under which the trial will be stopped with a claim of superiority for the experimental treatment, must, however, be determined in advance so as to control the overall type I error rate. One approach to calculating the stopping rule is the group-sequential method. A relatively recent alternative to group-sequential approaches is the adaptive design method. This latter approach provides considerable flexibility in changes to the design of a clinical trial at an interim point. However, a criticism is that the method by which evidence from different parts of the trial is combined means that a final comparison of treatments is not based on a sufficient statistic for the treatment difference, suggesting that the method may lack power. The aim of this paper is to compare two adaptive design approaches with the group-sequential approach. We first compare the form of the stopping boundaries obtained using the different methods. We then focus on a comparison of the power of the different trials when they are designed so as to be as similar as possible. We conclude that all methods acceptably control type I error rate and power when the sample size is modified based on a variance estimate, provided no interim analysis is so small that the asymptotic properties of the test statistic no longer hold. In the latter case, the group-sequential approach is to be preferred. Provided that asymptotic assumptions hold, the adaptive design approaches control the type I error rate even if the sample size is adjusted on the basis of an estimate of the treatment effect, showing that the adaptive designs allow more modifications than the group-sequential method.
Similar articles
- Self-designing trial combined with classical group sequential monitoring.
Yin G, Shen Y. Yin G, et al. J Biopharm Stat. 2005;15(4):667-75. doi: 10.1081/BIP-200062850. J Biopharm Stat. 2005. PMID: 16022171 - Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC. Morgan CC. Stat Med. 2003 Dec 30;22(24):3843-57. doi: 10.1002/sim.1677. Stat Med. 2003. PMID: 14673942 - Increasing the sample size when the unblinded interim result is promising.
Chen YH, DeMets DL, Lan KK. Chen YH, et al. Stat Med. 2004 Apr 15;23(7):1023-38. doi: 10.1002/sim.1688. Stat Med. 2004. PMID: 15057876 - Group-sequential methods for adaptive seamless phase II/III clinical trials.
Stallard N. Stallard N. J Biopharm Stat. 2011 Jul;21(4):787-801. doi: 10.1080/10543406.2011.551335. J Biopharm Stat. 2011. PMID: 21516569 Review. - The advantages and disadvantages of adaptive designs for clinical trials.
Bauer P, Brannath W. Bauer P, et al. Drug Discov Today. 2004 Apr 15;9(8):351-7. doi: 10.1016/S1359-6446(04)03023-5. Drug Discov Today. 2004. PMID: 15081962 Review.
Cited by
- Adaptive designs in clinical trials: a systematic review-part I.
Ben-Eltriki M, Rafiq A, Paul A, Prabhu D, Afolabi MOS, Baslhaw R, Neilson CJ, Driedger M, Mahmud SM, Lacaze-Masmonteil T, Marlin S, Offringa M, Butcher N, Heath A, Kelly LE. Ben-Eltriki M, et al. BMC Med Res Methodol. 2024 Oct 4;24(1):229. doi: 10.1186/s12874-024-02272-9. BMC Med Res Methodol. 2024. PMID: 39367313 Free PMC article. - A systematic review of randomised controlled trials with adaptive and traditional group sequential designs - applications in cardiovascular clinical trials.
Zhang J, Saju C. Zhang J, et al. BMC Med Res Methodol. 2023 Sep 7;23(1):200. doi: 10.1186/s12874-023-02024-1. BMC Med Res Methodol. 2023. PMID: 37679710 Free PMC article. - Interim data monitoring in cluster randomised trials: Practical issues and a case study.
Hemming K, Martin J, Gallos I, Coomarasamy A, Middleton L. Hemming K, et al. Clin Trials. 2021 Oct;18(5):552-561. doi: 10.1177/17407745211024751. Epub 2021 Jun 22. Clin Trials. 2021. PMID: 34154426 Free PMC article. Clinical Trial. - Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous system.
Mulcahey MJ, Jones LAT, Rockhold F, Rupp R, Kramer JLK, Kirshblum S, Blight A, Lammertse D, Guest JD, Steeves JD. Mulcahey MJ, et al. Spinal Cord. 2020 Dec;58(12):1235-1248. doi: 10.1038/s41393-020-00547-8. Epub 2020 Sep 16. Spinal Cord. 2020. PMID: 32939028 Review. - Designing and conducting proof-of-concept chronic pain analgesic clinical trials.
Campbell CM, Gilron I, Doshi T, Raja S. Campbell CM, et al. Pain Rep. 2019 Feb 26;4(3):e697. doi: 10.1097/PR9.0000000000000697. eCollection 2019 May-Jun. Pain Rep. 2019. PMID: 31583338 Free PMC article.